Anti Depression Drugs Market - By Depression Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others) By Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine reuptake Inhibitors, Monoamine oxidase inhibitors, Serotonin antagonist and reuptake inhibitors, Others) - By Region (North America, Europe, Asia Pacific, Middle East & Africa, RoW) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 201
Status: Published
Report Code: ARI100822
With the poor efficacy and safety profiles of the drug, increasing number of patient expiration, and preference for non-pharmacological therapies, and increasing count of deaths due to stress, the demand for the global anti depression market is anticipated to hamper the growth over the forecast period.
Anti depression drugs are generally used for the treatment of depressive disorders including chronic pain, obsessive compulsive disorder, dysthymia, anxiety, eating disorders, and neuropathic pain. Depression is a disorder which is related to the brain and it happens due to the increasing stress level, improper routine, unhealthy diet, minimum hours of sleep, and more. Moreover, the symptoms of depression include reduced energy, feeling emotionally sad, and difficulty in enjoying routine activities.
According to the CDC, depression is often seen in the people in the United States. In line to the World Health Organization, over 350 million people have been expected to go through depression disorder. Depression affects over 10% to 15% men and about 10% to 25% of women.
In terms of market players, the global anti depression market is competitive and fragmented with the presence of various kinds of different vendors including Takeda Pharmaceutical Co. Ltd., Allergan Plc, Eli Lilly and Co., H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Bristol Myers Squibb Co., Opko Health, Novartis, Forest Laboratories, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lupin, Abbott Laboratories, Alkermes Plc, and AstraZeneca.
Analyst Commentary
With the growing number of patients who are affected by the depression, the demand for the anti-depression market is expected to project lucrative growth over the forecast period. The depression takes place due to the improper lifestyle and routine, inappropriate sleep, unhealthy diet, and lack of physical activities. Thus, routine exercise is believed to be the major factor to cure from depression.
Most of the leading players are looking forward to expanding their distribution network with an intention to promote their businesses and increase the graphs of profit margins. Moreover, the emerging nations such as the Middle East & Africa, Asia Pacific, and Latin America are on the verge to increase prevalence of various types of depressive disorders and improving economic conditions. With the growing differences in clinical efficacy and drugs, most of the modern antidepressants work through common biological mechanisms.
Due to the steady growth, the industry is planning for the expansion of services programs for research and development of anti depression drugs solutions to be prepared for the battle-ground communication systems. This boosts the growth of the global anti depression market in the coming years. The leading companies in the global anti depression market are planning strategies such as joint ventures to generate long-term profits, acquisitions, and strengthen the product assortment.
Segmentation
The global anti depression market is categorized into several segmentations including depression disorder overview, product overview, and regions. Based on the depression disorder overview, the global anti depression market is fragmented into Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic Disorder, Major Depressive Disorder, and Others. Based on the product type overview, the global anti depression market is segregated into Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine oxidase inhibitors, Serotonin antagonist, reuptake inhibitors, Serotonin-norepinephrine reuptake Inhibitors, and Others. The depression disorder type segment is about to project faster growth along with tremendous popularity in the market owing to a growing population suffering from stress, rising concerns in awareness about the disease state and required clinical needs. This boosts the demand for the global anti depression market with a tremendous growth over the forecast period.
Regional Analysis
Based on region, the global anti depression market is widespread to the Middle East and Africa, Egypt, Saudi Arabia, Canada, South Africa, Asia Pacific, Argentina, Mexico, Korea, India, France, Turkey, Nigeria, UAE, Europe, Japan, China, UK, Russia, South America, Brazil, Italy, North America, Southeast Asia, Germany, USA, and Columbia.
North America is anticipated to hold the largest market size in the global anti depression market, followed by Europe. This is due to the increasing presence of key vendors in the region. Furthermore, Europe is expected to hold the highest market size in the market resulting in GDPR compliance. Due to the increasing technological advancement in Asia Pacific region, the factors influencing the anti depression market include growing prevalence of depression, emergence of novel techniques for the development of drugs with fewer side-effects, and rising geriatric population.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Anti Depression Drugs Market
Chapter 5. Global Anti Depression Drugs Market Overview, By Depression Disorder, 2015 – 2027 (USD Million)
5.1. Global Anti Depression Drugs Market Share, By Depression Disorder, 2020 & 2027 (%)
5.1.1. Major Depressive Disorder
5.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.2. Obsessive-Compulsive Disorder
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.3. Generalized Anxiety Disorder
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.4. Panic Disorder
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.5. Others
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 6. Global Anti Depression Drugs Market Overview, By Product, 2015 – 2027 (USD Million)
6.1. Global Anti Depression Drugs Market Share, By Product, 2020 & 2027 (%)
6.1.1. Tricyclic Antidepressants
6.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.2. Selective Serotonin Reuptake Inhibitors
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.3. Serotonin-norepinephrine reuptake Inhibitors
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.4. Monoamine oxidase inhibitors
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.5. Serotonin antagonist and reuptake inhibitors
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 7. Global Anti Depression Drugs Market Overview, By Geography, 2015 - 2027 (USD Million)
7.1. Global Anti Depression Drugs Market Share, By Geography, 2015 - 2027(USD Million)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 8. North America Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
8.1. North America Anti Depression Drugs Market Overview, 2020 & 2027 (%)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
8.1.3. North America Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
8.1.4. North America Anti Depression Drugs Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Anti Depression Drugs Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Anti Depression Drugs Market Overview, By Product, 2015 - 2027 (USD Million)
8.1.4.2. Canada Anti Depression Drugs Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Anti Depression Drugs Market Overview, By Product, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Anti Depression Drugs Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Anti Depression Drugs Market Overview, By Product, 2015 - 2027 (USD Million)
Chapter 9. Europe Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. Europe Anti Depression Drugs Market Overview, 2020 & 2027 (%)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027 (USD Million)
9.1.3. Europe Anti Depression Drugs Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.4. Europe Anti Depression Drugs Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Anti Depression Drugs Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.4.1.4. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.5. France Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
9.1.4.1.6. France Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
9.1.4.2. UK
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. UK Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
9.1.4.2.3. UK Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
9.1.4.3. Italy
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. Italy Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
9.1.4.3.3. Italy Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
9.1.4.4. Spain
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Spain Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
9.1.4.4.3. Spain Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
9.1.4.5. Rest of Europe
9.1.4.5.1. Market size and projections, 2015 – 2025
9.1.4.5.2. Rest of Europe Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
9.1.4.5.3. Rest of Europe Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
Chapter 10. Asia Pacific Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Asia Pacific Anti Depression Drugs Market Overview, 2020 & 2027(%)
10.1.1. Market size and projections, 2015 - 2027(USD Million)
10.1.2. Asia Pacific Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.3. Asia Pacific Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
10.1.4. Asia Pacific Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.1.2. India Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.4.1.3. India Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.2.2. China Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.4.2.3. China Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.3.2. Japan Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.4.3.3. Japan Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.4.2. South Korea Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.4.4.3. South Korea Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.5.2. Rest of Asia Pacific Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
10.1.4.5.3. Rest of Asia Pacific Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
Chapter 11. Middle East & Africa Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Middle East & Africa Anti Depression Drugs Market Overview, 2015 - 2027(USD Million)
11.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.2. Middle East & Africa Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
11.1.3. Middle East & Africa Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
11.1.4. Middle East & Africa Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.4.1.2. GCC Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
11.1.4.1.3. GCC Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
11.1.4.1.4. Market size and projections, 2015 - 2027(USD Million)
11.1.4.1.5. South Africa Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
11.1.4.1.6. South Africa Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
11.1.4.2. Rest of Middle East & Africa
11.1.4.2.1. Market size and projections, 2015 - 2027(USD Million)
11.1.4.2.2. Rest of Middle East & Africa Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
Chapter 12. South America Anti Depression Drugs Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. South America Anti Depression Drugs Market Overview, 2015 - 2027(USD Million)
12.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.2. South America Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
12.1.3. South America Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
12.1.4. South America Anti Depression Drugs Market Overview, By Countries, 2015- 2026(USD Million)
12.1.5. Brazil
12.1.5.1. Market size and projections, 2015 - 2027(USD Million)
12.1.5.2. Brazil Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
12.1.5.3. Brazil Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
12.1.6. Argentina
12.1.6.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.2. Argentina Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
12.1.6.3. Argentina Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
12.1.7. Rest of South America
12.1.7.1. Market size and projections, 2015 – 2027
12.1.7.2. Rest of South America Anti Depression Drugs Market Overview, By Depression Disorder, 2015 - 2027(USD Million)
12.1.7.3. Rest of South America Anti Depression Drugs Market Overview, By Product, 2015 - 2027(USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New product development
Chapter 14. Key Vendor Analysis
14.1. Takeda Pharmaceutical Co. Ltd
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Allergan Plc
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Teva Pharmaceutical Industries Ltd
14.4. Merck & Co.
14.5. Pfizer Inc
14.6. Others
Chapter 15. Anti Depression Drugs Market Cost Analysis
15.1. Key Raw Materials Analysis
15.1.1. Key Raw Materials
15.1.2. Price Trend of Anti Depression Drugs Market Key Raw Materials
15.1.3. Key Suppliers of Raw Materials
15.1.4. Market Concentration Rate of Raw Materials
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Industrial Chain Analysis
16.2. Upstream Raw Materials Sourcing
16.3. Raw Materials Sources of Anti Depression Drugs Market Major Manufacturers in 2020
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Industry
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Anti Depression Drugs Market share, By Depression Disorder, 2020 & 2027 (%)
10. Global Anti Depression Drugs Market, by Major Depressive Disorder, By Depression Disorder, 2015 - 2027(USD Million)
11. Global Anti Depression Drugs Market, by Obsessive-Compulsive Disorder, By Depression Disorder, 2015 - 2027(USD Million)
12. Global Anti Depression Drugs Market, by Generalized Anxiety Disorder, By Depression Disorder, 2015 - 2027(USD Million)
13. Global Anti Depression Drugs Market, by Panic Disorder, By Depression Disorder, 2015 - 2027(USD Million)
14. Global Anti Depression Drugs Market, by Others, By Depression Disorder, 2015 - 2027(USD Million)
15. Global Anti Depression Drugs Market share, By Product, 2020 & 2027 (%)
16. Global Anti Depression Drugs Market, by Tricyclic Antidepressants, By Product, 2015 - 2027(USD Million)
17. Global Anti Depression Drugs Market, by Selective Serotonin Reuptake Inhibitors, By Product, 2015 - 2027(USD Million)
18. Global Anti Depression Drugs Market, by Serotonin-norepinephrine reuptake Inhibitors, By Product, 2015 - 2027(USD Million)
19. Global Anti Depression Drugs Market, by Monoamine oxidase inhibitors, By Product, 2015 - 2027(USD Million)
20. Global Anti Depression Drugs Market, by Serotonin antagonist and reuptake inhibitors, By Product, 2015 - 2027(USD Million)
21. Global Anti Depression Drugs Market, by Others, By Product, 2015 - 2027(USD Million)
22. Global Anti Depression Drugs Market share, by region, 2020 & 2027 (%)
23. North America Anti Depression Drugs Market, 2020 - 2027(USD Million)
24. North America Anti Depression Drugs Market share, by Countries, 2020 & 2027 (%)
25. U.S. Anti Depression Drugs Market, 2020 - 2027(USD Million)
26. Canada Anti Depression Drugs Market, 2020 - 2027(USD Million)
27. Europe Anti Depression Drugs Market, 2020 - 2027(USD Million)
28. Europe Anti Depression Drugs Market share, by Countries, 2020 & 2027 (%)
29. Spain Anti Depression Drugs Market, 2020 - 2027(USD Million)
30. UK Anti Depression Drugs Market, 2020 - 2027(USD Million)
31. Italy Anti Depression Drugs Market, 2020 - 2027(USD Million)
32. Germany Anti Depression Drugs Market, 2020 - 2027(USD Million)
33. France Anti Depression Drugs Market, 2020 - 2027(USD Million)
34. Rest of Europe Anti Depression Drugs Market, 2020 - 2027(USD Million)
35. Asia-Pacific Anti Depression Drugs Market, 2020 - 2027(USD Million)
36. Asia-Pacific Anti Depression Drugs Market share, by Countries, 2020 & 2027 (%)
37. China Anti Depression Drugs Market, 2020 - 2027(USD Million)
38. India Anti Depression Drugs Market, 2020 - 2027(USD Million)
39. Australia Anti Depression Drugs Market, 2020 - 2027(USD Million)
40. Japan Anti Depression Drugs Market, 2020 - 2027(USD Million)
41. Rest of Asia-Pacific Anti Depression Drugs Market, 2020 - 2027(USD Million)
42. Middle East & Africa Anti Depression Drugs Market, 2020 - 2027(USD Million)
43. Middle East & Africa Anti Depression Drugs Market share, by Countries, 2020 & 2027 (%)
44. GCC Anti Depression Drugs Market, 2020 - 2027(USD Million)
45. South Africa Anti Depression Drugs Market, 2020 - 2027(USD Million)
46. Rest Of Middle East & Africa Anti Depression Drugs Market, 2020 - 2027(USD Million)
47. South America Anti Depression Drugs Market, 2020 - 2027(USD Million)
48. Brazil Anti Depression Drugs Market, 2020 - 2027(USD Million)
49. Mexico Anti Depression Drugs Market, 2020 - 2027(USD Million)
50. Argentina Anti Depression Drugs Market, 2020 - 2027(USD Million)
51. Rest of South America Anti Depression Drugs Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Anti Depression Drugs Market, 2015-2027(USD Million)
4. Global Anti Depression Drugs Market requirement, by country, 2015-2027,(USD Million)
5. North America Anti Depression Drugs Market, By Depression Disorder, 2015-2027(USD Million)
6. North America Anti Depression Drugs Market, By Product, 2015-2027(USD Million)
7. Europe Anti Depression Drugs Market, By Depression Disorder, 2015-2027(USD Million)
8. Europe Anti Depression Drugs Market, By Product, 2015-2027(USD Million)
9. Asia Pacific Anti Depression Drugs Market, By Depression Disorder, 2015-2027(USD Million)
10. Asia Pacific Anti Depression Drugs Market, By Product, 2015-2027(USD Million)
11. Middle East & Africa Anti Depression Drugs Market, By Depression Disorder, 2015-2027(USD Million)
12. Middle East & Africa Anti Depression Drugs Market, By Product, 2015-2027(USD Million)
13. South America Anti Depression Drugs Market, By Depression Disorder, 2015-2027(USD Million)
14. South America Anti Depression Drugs Market, By Product, 2015-2027(USD Million)
15. Global Anti Depression Drugs Market, Company Market Share, 2020 (%)
16. Takeda Pharmaceutical Co. Ltd: Product Benchmarking
17. Takeda Pharmaceutical Co. Ltd: Financial Performance
18. Allergan Plc: Product Benchmarking
19. Allergan Plc: Financial Performance
20. Teva Pharmaceutical Industries Ltd: Product Benchmarking
21. Teva Pharmaceutical Industries Ltd: Financial Performance
22. Merck & Co.: Product Benchmarking
23. Merck & Co.: Financial Performance
24. Pfizer Inc: Product Benchmarking
25. Pfizer Inc: Financial Performance
The Leading Key Players in Anti Depression Drugs Market
Takeda Pharmaceutical Co. Ltd.
Allergan Plc
Eli Lilly and Co.
H. Lundbeck
Merck & Co. Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline Plc
Bristol Myers Squibb Co.
Opko Health
Novartis
Forest Laboratories
Intra-Cellular Therapies
Janssen Pharmaceuticals
Lupin
Abbott Laboratories
Alkermes Plc
AstraZeneca.
